WELTRUZA™ receives FDA Approval • View webcast replay

Events Investors

Videoconference • Annual results

By MedincellJune 6, 2021March 15th, 2024No Comments

Download transcript

Download PDF presentation

Download press release

Previous PostVideoconference and publication of the results for the 2020-2021 financial year, on June 16, 2021
Next PostMedinCell’s Long-Acting Injectable to fight Malaria ready to enter Regulatory Development